New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 4, 2014
07:03 EDTCYCCCyclacel Pharmaceuticals 2.857M share Spot Secondary priced at $3.50
Laidlaw & Company is the sole book-running manager for the offering.
News For CYCC From The Last 14 Days
Check below for free stories on CYCC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CYCC

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use